ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1353	National Cancer Institute	Html	en	Adult Non-Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of adult non-Hodgkin lymphoma	indolent lymphoma 0.429154 PUBMED Ab 0.422097 mediastinal B-cell lymphoma 0.454731 Low-grade MALT lymphoma 0.426029 indolent follicular lymphoma 0.463176 Engl J Med 0.422774 International Lymphoma Study 0.450979 T-cell non-Hodgkin lymphoma 0.425991 advanced-stage follicular lymphoma 0.451924 Lymphoma Study Group 0.535602 large cell lymphoma 0.468204 peripheral t-cell lymphoma 0.456381 lymphoid tissue lymphoma 0.492221 B-cell gastric lymphoma 0.454154 large b-cell lymphoma 0.673742 low-grade follicular lymphoma 0.465805 Clin Lymphoma Myeloma 0.48896 gastric MALT lymphoma 0.456031 Follicular Lymphoma International 0.455402 diffuse large b-cell 0.567142 anaplastic large-cell lymphoma 0.485835 nodal follicular lymphoma 0.485707 Follicular Lymphoma Therapy 0.460112 marginal-zone B-cell lymphoma 0.442434 et al. 0.657474	follicular large-cell lymphoma 0.442424 advanced-stage non-Hodgkin lymphoma 0.443686 natural killer/t-cell lymphoma 0.443936 mucosa-associated lymphoid tissue 0.475564 PUBMED Abstract 0.461097 diffuse large-B-cell lymphoma 0.442818 primary follicular lymphoma 0.490523 low-grade gastric lymphoma 0.426685 mantle cell lymphoma 0.422703 follicular lymphoma 0.604182 Abstract 0.663115 lymphoplasmacytic lymphoma 0.440428 Clin Oncol 0.941 lymphoma 0.746021 international follicular lymphoma 0.455144 Low-Grade Lymphoma Study 0.438252 non-hodgkin lymphoma 0.449125 marginal zone lymphoma 0.509105 follicular lymphoma patients 0.482999 B-Cell Lymphoma Treated 0.458319 Systemic B-Cell Lymphoma 0.432957 MALT lymphoma 0.489467 Non-Hodgkin Lymphoma Study 0.426008 Lymphoma Classification Project 0.46454	CLICK HERE
1476	National Cancer Institute	Html	en	Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of adrenocortical carcinoma.	tumor marker 0.675202 out-of-phase T1-weighted imaging 0.697012 stage IV tumors 0.659343 metastatic functioning tumors 0.801327 staging tool 0.722476 PDQ cancer information 0.856921 metastatic lesions 0.771984 extracapsular tumor invasion 0.747406 staging systems 0.691871 potential lung metastasis 0.731171 adrenocortical carcinomas 0.63434 chemotherapeutic agent mitotane 0.781817 cancer information summary 0.816255 breast cancer prevention 0.687711 ENSAT staging 0.713932 mitotane antihormonal drugs 0.805561 malignant adrenal masses 0.717902 careful endocrine studies 0.718613 NCI’s PDQ 0.665371 PDQ Adult Treatment 0.724299 Proper staging 0.693902 NCI PDQ cancer 0.764668 Adrenal Tumors 0.670042 effective noninvasive method 0.696617 adrenal cancer 0.657663	radiation therapy 0.69704 long-term disease-free survival 0.704486 complete resection 0.734805 magnetic resonance imaging 0.900392 complete tumor resection 0.779736 excessive hormone production 0.742148 measurable tumor burden. 0.740477 steroid receptor antagonists 0.687573 hormone production 0.798926 5-year survival 0.724946 National Cancer Institute 0.688962 le Cancer staging 0.787658 PDQ documents 0.647653 useful clinical responses 0.679315 adrenal mass. 0.63451 World Health Organization. 0.685412 measurable partial remissions 0.680413 adrenocortical carcinoma 0.73628 primary tumor 0.750316 adjuvant mitotane 0.712566 above-mentioned AJCC staging 0.781955 American Joint Committee 0.694648 regional lymph nodes 0.695067 Overall 5-year survival 0.710773	CLICK HERE
1486	National Cancer Institute	Html	en	Melanoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of melanoma.	temozolomide versus dacarbazine 0.706064 standard therapy arm 0.513108 individual treatment sections 0.538046 single-agent inhibitor 0.443006 BRAF-mutated metastatic melanoma 0.711751 Val600 BRAF-mutant melanoma 0.627182 drug targets 0.434691 clinical trial design 0.573658 Drug Administration 0.434687 primary endpoint 0.423708 DTIC 0.525789 MEK inhibitor 0.453277 rare CRs 0.424667 active moiety 0.422545 randomized trials. 0.46852 BRAF-mutant subtype 0.57943 phase III study 0.513517 important option 0.423407 phase iii trials 0.549837 oral alkylating agent 0.523779 clinical trials 0.434562 V600 mutant melanoma 0.640167 sample size 0.421859	palliative radiation therapy 0.502761 multicenter trial 0.445549 temozolomide group 0.594959 multiagent chemotherapy 0.434715 randomized trial 0.479926 first-line vs. 0.432084 Clin Oncol 0.536064 Combination therapies 0.426982 genomic subtypes 0.583162 superior OS 0.42215 recent registration trials 0.531572 guide clinical decision-making 0.554726 Grob JJ 0.535846 High-dose recombinant interleukin 0.518234 ECOG PS 0.423492 randomised phase 0.46148 metastatic melanoma 0.981501 previously untreated patients 0.74564 primary endpoints 0.427198 metastatic malignant melanoma 0.829145 stage IV melanoma 0.540818 U.S. Food 0.438775	CLICK HERE
1519	National Cancer Institute	Html	en	Rectal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of rectal cancer.	cancer treatment 0.518883 body 0.520416 PDQ cancer information 0.52558 clinical trial search 0.497998 new blood vessels 0.485963 Digital rectal exam 0.48424 clinical trials 0.752809 nearby lymph nodes 0.622455 cancer information summary 0.505272 clinical trial 0.589481 Rectal Cancer Treatment 0.502419 colorectal cancer 0.509773 patients 0.475547 metastatic rectal cancer 0.496375 vascular endothelial growth 0.472356 NCI PDQ cancer 0.475491 malignant tumor cells 0.468557 radiation therapy 0.598557 rectum 0.694659 treatment 0.642215 Recurrent rectal cancer 0.514414 nonpolyposis colorectal cancer 0.478736 nearby organs 0.553031 cancer prevention 0.463023	new cancer treatments 0.468973 NCI-supported cancer 0.477253 cancer cells 0.703626 entire rectum 0.4751 Cancer Information Service 0.470531 muscle layer 0.486714 specific cancer cells 0.477097 endothelial growth factor 0.47057 treatment clinical trials 0.482164 National Cancer Institute 0.505951 outermost layer 0.501883 new treatment 0.500006 rectal cancer spreads 0.494951 Colorectal Cancer section 0.478726 rectal cancer 0.877471 rectum wall 0.683123 Blood. The cancer 0.463452 cancer research process 0.463813 cancer clinical trials 0.522705 stage 0.526305 tumor 0.468782 cancer information summaries 0.468811 comprehensive cancer information 0.46866 cancer 0.995137	CLICK HERE
1583	National Cancer Institute	Html	null	Childhood Liver Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood liver cancer.			CLICK HERE
1679	National Cancer Institute	Html	en	Communication in Cancer Care (PDQ®)–Patient Version	It is important to talk to your doctor about your cancer diagnosis, goals of treatment, plan of care, and what to expect over time. Learn how good communication between patients, families, caregivers and doctors can improve the patient's quality of life in this expert-reviewed summary.	cancer treatment 0.389842 bad news 0.386292 questions 0.399361 PDQ cancer information 0.624305 health care team 0.981737 clinical trials 0.514782 Pediatric Supportive Care 0.404638 communication 0.486074 cancer information summary 0.515585 clinical trial 0.495706 family members 0.426143 cancer care 0.778281 breast cancer prevention 0.399685 PDQ summaries 0.394467 patients 0.573309 cancer patients 0.414288 team share information 0.427277 latest published information 0.403211 NCI’s PDQ 0.394236 PDQ summary Family 0.458483 NCI PDQ cancer 0.456705 supportive care 0.443184 treatment 0.599848 family caregivers 0.667411	cancer prevention 0.402033 Cancer Information Service 0.427003 Explain medical information 0.409499 PDQ Supportive 0.391221 patient 0.679815 PDQ Communication 0.403164 treatment clinical trials 0.401111 National Cancer Institute 0.597923 decisions 0.454448 PDQ documents 0.390179 Palliative Care Editorial 0.462952 medical information 0.462988 new treatment 0.398754 good communication 0.425774 Cancer Care page 0.429643 PDQ database 0.392979 Care Editorial Board 0.465833 PDQ summary 0.483184 doctor 0.450453 cancer clinical trials 0.415988 cancer information summaries 0.432334 comprehensive cancer information 0.43347 cancer patient 0.392432 cancer 0.840307	CLICK HERE
1760	National Cancer Institute	Html	en	Obesity and Cancer	A fact sheet that summarizes the evidence linking overweight and obesity to the risk of various cancers and to cancer survivorship.	obesity causes cancer 0.394065 normal-weight people 0.279732 observational studies 0.323456 obesity prevalence 0.293137 obesity 0.638496 thyroid cancer risk 0.290632 obese people 0.350767 risk factors 0.298103 multiple myeloma 0.271306 colorectal cancer 0.326707 ovarian cancer 0.293192 body mass index 0.723663 prostate cancer risk 0.293391 postmenopausal breast cancer 0.29585 weight loss 0.380764 endometrial cancer increases 0.279353 cancer incidence data 0.260252 different cancer risk 0.325913 breast cancer survivors 0.303032 kidney cancer 0.323356 endometrial cancer 0.299756 invasive breast cancer 0.260923 menopausal hormone therapy 0.326286 women 0.298824 gallbladder cancer 0.347557	United States 0.307003 weight gain 0.259995 male breast cancer 0.288797 breast cancer diagnosis 0.278716 pancreatic cancer 0.309076 different cancer types 0.265661 LeRoith D. Obesity 0.262512 National Cancer Institute 0.329185 extremely obese women 0.271426 renal cell cancer 0.355343 increase cancer risk 0.312393 breast cancer risk 0.439989 breast cancer 0.64758 C. Gallbladder cancer 0.256715 cancer survivorship 0.270564 prostate cancer 0.294021 Breast Cancer WEight 0.309447 pancreatic cancer risk 0.295039 breast cancer pooling 0.266031 prospective studies 0.320099 et al 0.828361 cancer risk 0.662021 cancer 0.97959 liver cancer 0.398322	CLICK HERE
1809	National Cancer Institute	Html	es	Tratamiento del cáncer de pulmón de células pequeñas (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de pulmón de células pequeñas.	Lung Cancer Cooperative 0.40923 small-cell carcinoma 0.409726 Arriagada R 0.406258 mortality from lung 0.406031 Pignon JP 0.406568 lung carcinoma 0.415433 chemotherapy with or 0.407857 thoracic irradiation 0.411758 lung cancer 0.99158 small-cell lung 0.732567 American Cancer Society 0.407972 limited-stage small-cell lung 0.528108 with once-daily thoracic 0.405556 Cancer Data Base 0.408315 tobacco-specific lung carcinogen 0.40968 Lung Oncology Group 0.405386 Radiat Oncol Biol 0.407067 Lung Cancer Group 0.40944 oncology group study 0.409486 Natl Cancer Inst 0.413727 Council Lung Cancer 0.408713 patients with 0.422455 cancer lung 0.415587 Does thoracic irradiation 0.406837 small cell carcinoma 0.40583	small-cell lung carcinoma 0.412738 childhood cancer 0.406909 with small-cell lung 0.428402 Lung Cancer Working 0.414426 National Cancer 0.425705 extensive small-cell lung 0.412452 Clinical Trials Group 0.406926 small cell lung 0.507254 National Cancer Institute 0.418442 prophylactic cranial irradiation 0.410926 combination chemotherapy with 0.405558 with combination chemotherapy 0.405558 National Cancer Data 0.408383 Clin Oncol 0.533689 Oncol Biol Phys 0.407177 combined modality treatment 0.409248 Low-dose lung 0.405724 Canada Clinical Trials 0.406735 treated with 0.408022 Cancer Working Party 0.407006 with or without 0.405778 lung tumours 0.405564 Cancer Survivor Study 0.405383 thoracic radiotherapy 0.433304	CLICK HERE
2061	National Cancer Institute	Html	es	Mamografías	Hoja informativa que define las mamografías de detección y de diagnóstico; trata de los beneficios y perjuicios posibles de las mamografías de detección; y resume cómo se reportan los resultados, incluso la densidad de los senos.	largo período 0.329403 federal affordable care 0.358034 mamografía digital 0.901811 Database System 0.32976 de estudios clínicos aleatorizados y 0.369135 técnica especial llamada 0.347452 programa brinda servicios 0.346724 posibles limitaciones 0.337532 rayos x 0.327782 breast self-exam 0.336335 Categoría Evaluación Seguimiento 0.350863 posibles perjuicios 0.338669 alta densidad 0.339314 tratamiento. Las mamografías 0.58289 pequeñas masas 0.327877 Exposición a radiación. Las mamografías 0.580742 Resultado benigno 0.343535 Breast Imaging Reporting 0.356725 pequeños depósitos de calcio 0.365542 Colegio Estadounidense 0.332034 seguro médico 0.544063	mujeres con implantes 0.382313 detección temprana 0.693756 Healthcare Research 0.333438 al feto en crecimiento 0.333178 casos de carcinoma 0.332936 Instituto Nacional 0.371979 Mammography Quality Standards 0.352873 mujer nota 0.33784 normales aun 0.335316 tanta rapidez 0.335356 usa luz 0.328978 3D usa dosis 0.354905 Requiere biopsia 0.343563 Estados Unidos 0.809815 pequeñas de radiación 0.330854 Cuello Uterino 0.329522 posibles beneficios 0.33135 positivos falsos. Los resultados 0.376938 ley mqsa 0.332395 decisiones médicas que 0.334533 mujeres jóvenes 0.457334	CLICK HERE
15649	National Cancer Institute	Html	en	Genomic Data Sharing (GDS) Policy	The NIH Genomic Data Sharing (GDS) Policy was issued to promote broad sharing of genomic research data and ensure oversight and protections for research involving human data.	Policy 0.279904 GDS 0.601385	National Cancer Institute 0.917963 Genomic Data 0.846899	CLICK HERE